This is a "must read"!
Schering-Plough’s CEO Fred Hassan has two years left to retirement as he faces the most serious challenge to his personal legacy: One failed trial, two Congressional investigations, subpoenas from the New York State Attorney General, an SEC investigation, and a brutal 40% drop in Schering-Plough stock price from its peak.
Until a few weeks ago Hassan was God's gift to the pharmaceutical industry (according to Forbes).
But was it all just a mirage--a skillfully played con-game?
More
1 comment:
Thanks Jack!
I think I'll rest now for a few days . .
Post a Comment